Overall, these findings highlight the essential function of CRABP2 in enhancing lipid biosynthesis and facilitating metastatic potential of NSCLC cells through the downregulation of PLAAT4. The gene discussed is PLAAT4; the disease is non-small cell lung carcinoma.